Literature DB >> 27531932

RBM20 Regulates Circular RNA Production From the Titin Gene.

Mohsin A F Khan1, Yolan J Reckman1, Simona Aufiero1, Maarten M G van den Hoogenhof1, Ingeborg van der Made1, Abdelaziz Beqqali1, Dave R Koolbergen1, Torsten B Rasmussen1, Jolanda van der Velden1, Esther E Creemers2, Yigal M Pinto2.   

Abstract

RATIONALE: RNA-binding motif protein 20 (RBM20) is essential for normal splicing of many cardiac genes, and loss of RBM20 causes dilated cardiomyopathy. Given its role in splicing, we hypothesized an important role for RBM20 in forming circular RNAs (circRNAs), a novel class of noncoding RNA molecules.
OBJECTIVE: To establish the role of RBM20 in the formation of circRNAs in the heart. METHODS AND
RESULTS: Here, we performed circRNA profiling on ribosomal depleted RNA from human hearts and identified the expression of thousands of circRNAs, with some of them regulated in disease. Interestingly, we identified 80 circRNAs to be expressed from the titin gene, a gene that is known to undergo highly complex alternative splicing. We show that some of these circRNAs are dynamically regulated in dilated cardiomyopathy but not in hypertrophic cardiomyopathy. We generated RBM20-null mice and show that they completely lack these titin circRNAs. In addition, in a cardiac sample from an RBM20 mutation carrier, titin circRNA production was severely altered. Interestingly, the loss of RBM20 caused only a specific subset of titin circRNAs to be lost. These circRNAs originated from the RBM20-regulated I-band region of the titin transcript.
CONCLUSIONS: We show that RBM20 is crucial for the formation of a subset of circRNAs that originate from the I-band of the titin gene. We propose that RBM20, by excluding specific exons from the pre-mRNA, provides the substrate to form this class of RBM20-dependent circRNAs.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  alternative splicing; cardiovascular system; dilated cardiomyopathy; hypertrophic cardiomyopathy; mutation

Mesh:

Substances:

Year:  2016        PMID: 27531932     DOI: 10.1161/CIRCRESAHA.116.309568

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  113 in total

Review 1.  Functional role of circular RNAs in cancer development and progression.

Authors:  Wei Lun Ng; Taznim Begam Mohd Mohidin; Kirti Shukla
Journal:  RNA Biol       Date:  2018-08-04       Impact factor: 4.652

Review 2.  Circular RNAs: A Novel Class of Functional RNA Molecules with a Therapeutic Perspective.

Authors:  Laura Santer; Christian Bär; Thomas Thum
Journal:  Mol Ther       Date:  2019-07-09       Impact factor: 11.454

Review 3.  A narrative review of circular RNAs as potential biomarkers and therapeutic targets for cardiovascular diseases.

Authors:  Chi Liu; Nan Li; Guifeng Dai; Omer Cavdar; Hong Fang
Journal:  Ann Transl Med       Date:  2021-04

4.  Circular RNA circPIKfyve acts as a sponge of miR-21-3p to enhance antiviral immunity through regulating MAVS in teleost fish.

Authors:  Hui Su; Qing Chu; Weiwei Zheng; Renjie Chang; Wenya Gao; Lei Zhang; Tianjun Xu
Journal:  J Virol       Date:  2021-02-03       Impact factor: 5.103

Review 5.  Circular RNA - New member of noncoding RNA with novel functions.

Authors:  Kuei-Yang Hsiao; H Sunny Sun; Shaw-Jenq Tsai
Journal:  Exp Biol Med (Maywood)       Date:  2017-05-09

Review 6.  Insights into circular RNA biology.

Authors:  Karoline K Ebbesen; Thomas B Hansen; Jørgen Kjems
Journal:  RNA Biol       Date:  2016-12-16       Impact factor: 4.652

Review 7.  Role of circular RNAs in cardiovascular diseases.

Authors:  Xue Gong; Gengze Wu; Chunyu Zeng
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-17

Review 8.  Translational Perspective on Epigenetics in Cardiovascular Disease.

Authors:  Pim van der Harst; Leon J de Windt; John C Chambers
Journal:  J Am Coll Cardiol       Date:  2017-08-01       Impact factor: 24.094

Review 9.  CircRNAs: a regulator of cellular stress.

Authors:  Joseph W Fischer; Anthony K L Leung
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-01-17       Impact factor: 8.250

10.  A circular RNA regulator quaking: a novel gold mine to be unfolded in doxorubicin-mediated cardiotoxicity.

Authors:  Tatsuya Aonuma; Ahmed S Bayoumi; Yaoliang Tang; Il-Man Kim
Journal:  Noncoding RNA Investig       Date:  2018-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.